These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11366807)

  • 1. HIV pediatric drug chart.
    Vazquez E
    Posit Aware; 1999; 10(4):48-50. PubMed ID: 11366807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaletra lower-strength pediatric tablet approved in Europe.
    AIDS Patient Care STDS; 2008 May; 22(5):437-8. PubMed ID: 18521973
    [No Abstract]   [Full Text] [Related]  

  • 3. Children on losing end of access to new drugs.
    AIDS Alert; 1998 Jan; 13(1):10-2. PubMed ID: 11364862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovir efficacy supplement approved.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043841
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
    AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980
    [No Abstract]   [Full Text] [Related]  

  • 6. Epivir for younger children.
    Vazquez E
    Posit Aware; 1999; 10(3):26. PubMed ID: 11366765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
    AIDS Alert; 2008 Nov; 23(11):128. PubMed ID: 19043870
    [No Abstract]   [Full Text] [Related]  

  • 8. ddI: FDA approves once-daily dosing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1999 Nov; (No 330):1. PubMed ID: 11367169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of recent guidelines for antiretroviral treatment of HIV-infected children.
    Oleske JM
    Top HIV Med; 2003; 11(6):180-4. PubMed ID: 14724326
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric efficacy supplement for Videx EC.
    AIDS Patient Care STDS; 2008 Nov; 22(11):919. PubMed ID: 19043843
    [No Abstract]   [Full Text] [Related]  

  • 11. Efavirenz: new preparation. An alternative to HIV protease inhibitors.
    Prescrire Int; 2000 Apr; 9(46):46-9. PubMed ID: 11503786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV antiviral drug guide 1997.
    Posit Aware; 1997; 8(1):24-33. PubMed ID: 11364095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.
    Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z
    Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV management requires strategic planning. Optimal sequencing of protease inhibitors].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():21-4. PubMed ID: 11373770
    [No Abstract]   [Full Text] [Related]  

  • 17. Initiating therapy: when to start, what to use.
    Hirsch MS
    J Infect Dis; 2008 May; 197 Suppl 3():S252-60. PubMed ID: 18447611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
    Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
    J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel treatment options for pediatric HIV infection.
    Day E; Buckberry K; Sharland MR; Chakraborty R
    Curr Opin Investig Drugs; 2008 Feb; 9(2):170-5. PubMed ID: 18246519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for third line therapy.
    Proj Inf Perspect; 2002 Mar; (34):8-9. PubMed ID: 12038303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.